PMC:7463108 / 66729-66901 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T652","span":{"begin":120,"end":131},"obj":"Body_part"},{"id":"T653","span":{"begin":144,"end":150},"obj":"Body_part"}],"attributes":[{"id":"A652","pred":"fma_id","subj":"T652","obj":"http://purl.org/sig/ont/fma/fma63261"},{"id":"A653","pred":"fma_id","subj":"T653","obj":"http://purl.org/sig/ont/fma/fma62977"}],"text":"Specifically, morphine-treated SIV macaques developed more subtle, focal, dysmyelinating lesions, with accumulations of macrophages in areas of myelin loss (Marcario et al."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T161","span":{"begin":144,"end":150},"obj":"Body_part"}],"attributes":[{"id":"A161","pred":"uberon_id","subj":"T161","obj":"http://purl.obolibrary.org/obo/UBERON_0000345"}],"text":"Specifically, morphine-treated SIV macaques developed more subtle, focal, dysmyelinating lesions, with accumulations of macrophages in areas of myelin loss (Marcario et al."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T160","span":{"begin":31,"end":34},"obj":"Disease"}],"attributes":[{"id":"A160","pred":"mondo_id","subj":"T160","obj":"http://purl.obolibrary.org/obo/MONDO_0010029"}],"text":"Specifically, morphine-treated SIV macaques developed more subtle, focal, dysmyelinating lesions, with accumulations of macrophages in areas of myelin loss (Marcario et al."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T81194","span":{"begin":14,"end":22},"obj":"Chemical"}],"attributes":[{"id":"A79314","pred":"chebi_id","subj":"T81194","obj":"http://purl.obolibrary.org/obo/CHEBI_17303"},{"id":"A74073","pred":"chebi_id","subj":"T81194","obj":"http://purl.obolibrary.org/obo/CHEBI_58097"}],"text":"Specifically, morphine-treated SIV macaques developed more subtle, focal, dysmyelinating lesions, with accumulations of macrophages in areas of myelin loss (Marcario et al."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2362","span":{"begin":31,"end":34},"obj":"Gene"},{"id":"2367","span":{"begin":14,"end":22},"obj":"Chemical"},{"id":"2375","span":{"begin":74,"end":96},"obj":"Disease"},{"id":"2376","span":{"begin":144,"end":155},"obj":"Disease"}],"attributes":[{"id":"A2362","pred":"tao:has_database_id","subj":"2362","obj":"Gene:8114"},{"id":"A2367","pred":"tao:has_database_id","subj":"2367","obj":"MESH:D009020"},{"id":"A2375","pred":"tao:has_database_id","subj":"2375","obj":"MESH:C563789"},{"id":"A2376","pred":"tao:has_database_id","subj":"2376","obj":"MESH:D020279"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Specifically, morphine-treated SIV macaques developed more subtle, focal, dysmyelinating lesions, with accumulations of macrophages in areas of myelin loss (Marcario et al."}

{"project":"LitCovid-sentences","denotations":[{"id":"T920","span":{"begin":0,"end":172},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Specifically, morphine-treated SIV macaques developed more subtle, focal, dysmyelinating lesions, with accumulations of macrophages in areas of myelin loss (Marcario et al."}